Literature DB >> 10201433

Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine.

C P Panayiotopoulos1.   

Abstract

This is a qualitative and chronological analysis of ictal and postictal symptoms, frequency of seizures, family history, response to treatment, and prognosis in nine patients with idiopathic occipital epilepsy and visual seizures. Ictal elementary visual hallucinations are stereotyped for each patient, usually lasting for seconds. They consist of mainly multiple, bright coloured, small circular spots, circles, or balls. Mostly, they appear in a temporal hemifield often moving contralaterally or in the centre where they may be flashing. They may multiply and increase in size in the course of the seizure and may progress to other non-visual occipital seizure symptoms and more rarely to extra-occipital manifestations and convulsions. Blindness occurs usually from the beginning and postictal headache, often indistinguishable from migraine, is common. It is concluded that elementary visual hallucinations in occipital seizures are entirely different from visual aura of migraine when individual elements of colour, shape, size, location, movement, speed of development, duration, and progress are synthesised together. Postictal headache does not show preference for those with a family history of migraine. Most of the patients are misdiagnosed as having migraine with aura, basilar migraine, acephalgic migraine, or migralepsy simply because physicians are not properly informed of differential diagnostic criteria. As a result, treatment may be delayed for years. Response to carbamazepine is excellent and seizures may remit.

Entities:  

Mesh:

Year:  1999        PMID: 10201433      PMCID: PMC1736305          DOI: 10.1136/jnnp.66.4.536

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  27 in total

1.  Visual hallucinations: differential diagnosis and treatment.

Authors:  Ryan C Teeple; Jason P Caplan; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 2.  Migraine and epilepsy in the pediatric population.

Authors:  Christopher B Oakley; Eric H Kossoff
Journal:  Curr Pain Headache Rep       Date:  2014-03

Review 3.  The complex interrelations between two paroxysmal disorders: headache and epilepsy.

Authors:  Carlo Cianchetti; Giuliano Avanzini; Filippo Dainese; Vincenzo Guidetti
Journal:  Neurol Sci       Date:  2017-03-24       Impact factor: 3.307

Review 4.  [Syncope, transient ischemic attacks, transient global amnesia and migraine].

Authors:  E Hartl
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

Review 5.  Migralepsy: a borderland of wavy lines.

Authors:  Amy Z Crepeau
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 6.  Visual hallucinations and the Charles Bonnet syndrome.

Authors:  Dominic H Ffytche
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

7.  Neuropsychological profile of adult patients with nonsymptomatic occipital lobe epilepsies.

Authors:  Leonilda Bilo; Gabriella Santangelo; Ilaria Improta; Carmine Vitale; Roberta Meo; Luigi Trojano
Journal:  J Neurol       Date:  2012-08-18       Impact factor: 4.849

8.  Visual Hallucinations.

Authors:  Victoria S. Pelak; Grant T. Liu
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

Review 9.  Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations.

Authors:  T T Winton-Brown; A Ting; R Mocellin; M Walterfang; D Velakoulis; F Gaillard
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

10.  Benign epilepsy of childhood with centro-temporal spikes (BECTS) versus migraine: a neuropsychological assessment.

Authors:  Pasquale Parisi; Sara Matricardi; Elisabetta Tozzi; Enzo Sechi; Claudia Martini; Alberto Verrotti
Journal:  Childs Nerv Syst       Date:  2012-09-08       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.